Resources

Longitudinal Evaluation of Circulating Tumor DNA Using Sensitive Amplicon-Based Next-Generation Sequencing to Identify Resistance Mechanisms to Immune Checkpoint Inhibitors for Advanced Urothelial Carcinoma

• Journal Title: The Oncologist
• Author: Praful Ravi, Arvind Ravi, Irbaz B Riaz, Dory Freeman, Catherine Curran, Charlene Mantia, Bradley A McGregor, Kerry L Kilbridge, Chong-Xian Pan, Michelle Pek, Yukti Choudhury, Min-Han Tan, Guru P Sonpavde

Analytical and clinical validation of an amplicon-based next generation sequencing assay for ultrasensitive detection of circulating tumor DNA

• Journal Title: PLOS One
• Author: Jonathan Poh, Kao Chin Ngeow, Michelle Pek, Kian-Hin Tan, Jing Shan Lim, Hao Chen, Choon Kiat Ong, Jing Quan Lim, Soon Thye Lim, Chwee Ming Lim, Boon Cher Goh, Yukti Choudhury

Complementing Tissue Testing with Plasma Mutation Profiling Improves Therapeutic Decision Making for Lung Cancer Patient

• Journal Title: Frontiers in Medicine
• Author: Yukti Choudhury, Min-Han Tan, Jun Li Shi, Augustine Tee, Kao Chin Ngeow, Jonathan Poh, Ruth Rosalyn Goh, Jamie Mong

Analytical and Clinical Validation of an Amplicon-based Next Generation Sequencing Assay for Ultrasensitive Detection of Circulating Tumor DNA

• Journal Title: medRxiv
• Author: Jonathan Poh, Kao Chin Ngeow, Michelle Pek, Kian-Hin Tan, Jing Shan Lim, Hao Chen, Choon Kiat Ong, Jing Quan Lim, Soon Thye Lim, Chwee Ming Lim, Boon Cher Goh, Yukti Choudhury

Lucence Presents New Data on Liquid Biopsy for Late-stage Cancer Monitoring, Treatment Guidance

• Journal Title: GenomeWeb
• Author: John Gilmore

AmpliMark™ Technical Sheet